DCTH
NASDAQ HealthcareDelcath Systems, Inc. - Common Stock
Medical Devices
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
๐ Market Data
| Price | $10.80 |
|---|---|
| Volume | 169,780 |
| Market Cap | 375.26M |
| Beta | 0.430 |
| RSI (14-Day) | 55.0 |
| 200-Day MA | $10.19 |
| 50-Day MA | $9.80 |
| 52-Week High | $18.23 |
| 52-Week Low | $8.12 |
| P/E Ratio | 154.29 |
| Forward P/E | -55.10 |
| Price / Book | 3.37 |
๐ฏ Investment Strategy Scores
DCTH scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (48/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ Institutional Whale (9/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find DCTH in your text
Paste any article, transcript, or post โ the tool will extract DCTH and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.